Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02499354 · ClinicalTrials.gov registry record · Phase 2
Pilot Study: Randomized, Placebo-controlled Comparator Trial of IV vs Oral Iron Treatment of RLS With IDA. (IVOR-IDA)
A Phase 2 study, sponsored by Auerbach Hematology Oncology Associates P C.
- Completed
- Registry status
- Phase 2
- Development phase
- 100
- Enrollment target
NCT02499354: Completed Phase 2 study, sponsored by Auerbach Hematology Oncology Associates P C.
NCT02499354 is a Phase 2 study that has completed, run by Auerbach Hematology Oncology Associates P C. The registered enrollment target is 100 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (25% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02499354, a Phase 2 study, has completed, sponsored by Auerbach Hematology Oncology Associates P C.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 100 participants
- Enrollment target
Study Summary
The purpose of the study is to determine the relative effect size of standard IV and oral iron treatment of RLS with Iron deficiency anemia (IDA) and to determine the time course of treatment response.
Primary Outcome
Change in International Restless Legs Severity Scale (IRLS) score reflecting RLS severity on the scale of 0-40. The higher the negative score the better the outcome
Interventions
- DRUG Ferrous sulfate
- DRUG Ferumoxytol intravenous
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2014-08 |
| Est. Completion | 2022-05-31 |
| Phase | Phase 2 |
What the finished NCT02499354 record still lists
NCT02499354 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (25% lower).
The record links to 0 conditions, and to 2 interventions - of which Ferrous sulfate is the first listed.
NCT02499354 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02499354 about?
NCT02499354 is a clinical study titled "Pilot Study: Randomized, Placebo-controlled Comparator Trial of IV vs Oral Iron Treatment of RLS With IDA. (IVOR-IDA)". The purpose of the study is to determine the relative effect size of standard IV and oral iron treatment of RLS with Iron deficiency anemia (IDA) and to determine the time course of treatment response.
What is the current status of trial NCT02499354?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 100 participants. The study started on 2014-08. Estimated completion is 2022-05-31.
What interventions are being tested in trial NCT02499354?
The interventions under investigation include: Ferrous sulfate (DRUG), Ferumoxytol intravenous (DRUG).
Who is sponsoring clinical trial NCT02499354?
This trial is sponsored by Auerbach Hematology Oncology Associates P C, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02499354's enrollment target sits among peer trials
100 672nd of 2000 higher than 1,263 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia